<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02286908</url>
  </required_header>
  <id_info>
    <org_study_id>2013/573/REK sør-øst</org_study_id>
    <nct_id>NCT02286908</nct_id>
  </id_info>
  <brief_title>Global Strain and Mechanical Dispersion May Predict Death and Ventricular Arrhythmias Better Than Ejection Fraction</brief_title>
  <official_title>Improved Prediction of Clinical Outcome With the Use of Global Strain and Mechanical Dispersion in Patients With Myocardial Infarction and Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>South-Eastern Norway Regional Health Authority</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate if global strain and mechanical dispersion may predict
      death and ventricular arrhythmias better than ejection fraction(EF) in patients with
      myocardial infarction and heart failure regardless of cause.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. The main aim of this study is to investigate if global strain and mechanical dispersion
           may predict death and ventricular arrhythmias better than left ventricular ejection
           fraction in patients with myocardial infarction and heart failure.

        2. In patients who receive internal cardioverter defibrillator(ICD) the main aim is to
           investigate if mechanical dispersion may predict ventricular arrhythmias better than EF.

      3) No interventions,only evaluation of the measurements obtained with transthoracic
      echocardiography.

      4) Follow up for 3 years
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 2014</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ventricular arrhythmia and death after acute myocardial infarction or heart failure.</measure>
    <time_frame>3 years</time_frame>
    <description>Arrhythmic events during follow-up are defined as documented sustained ventricular tachycardia, ventricular fibrillation, and SCD. Survival is assessed by medical charts if patients are within the uptake area of the hospital and by the Norwegian death registry Folkeregisteret.</description>
  </primary_outcome>
  <enrollment type="Anticipated">3100</enrollment>
  <condition>Left Ventricular Function Systolic Dysfunction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with myocardial infarction, heart failure and patients planned for primary
        prophylactic ICD. Echocardiography is performed at inclusion. Comparism of the ability of
        left ventricular ejection fraction, global strain and mechanical dispersion to predict
        clinical outcome in patients with these conditions.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with

               1. myocardial infarction

               2. heart failure( defined as heart failure symptoms: reduced left ventricular
                  function/ and or heart failure signs on chest x ray.

               3. planned for primary prophylactic ICD

          -  over 18 years of age

          -  Informed consent

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thor Edvardsen, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thor Edvardsen, MD, PHD</last_name>
    <email>thor.edvardsen@medisin.uio.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Harald Brunvand, MD, PHD</last_name>
    <email>harbrun@online.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vseobecna fakultni nemocnice Praha/ Prague General hospital</name>
      <address>
        <city>Prague</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josef Marek</last_name>
      <email>jsfmarek@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sørlandet sykehus Arendal</name>
      <address>
        <city>Arendal</city>
        <state>Agder</state>
        <zip>4800</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Melichova, MD</last_name>
      <email>daniela.melichova@sshf.no</email>
    </contact>
    <contact_backup>
      <last_name>Thuy Mi Nguyen, MD</last_name>
      <email>thuy.mi.nguyen@sshf.no</email>
    </contact_backup>
    <investigator>
      <last_name>Daniela Melichova, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thuy Mi Nguyen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ivar Mjåland Salte, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vestre Viken HF</name>
      <address>
        <city>Drammen</city>
        <zip>3004</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erik Gjertsen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sørlandet sykehus Kristiansand</name>
      <address>
        <city>Kristiansand</city>
        <zip>4604</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Finn Tore Gjestvang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oslo university hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thor Edvardsen, MD, PhD</last_name>
      <email>thor.edvardsen@medisin.uio.no</email>
    </contact>
    <investigator>
      <last_name>Lars Gunnar Klæboe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sykehuset Telemark HF</name>
      <address>
        <city>Skien</city>
        <zip>3710</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacob Thalamus</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stavanger universitetssjukehus</name>
      <address>
        <city>Stavanger</city>
        <zip>4068</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dennis Nilsen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitetssykehuset Nord Norge, Tromsø</name>
      <address>
        <city>Tromsø</city>
        <zip>9038</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pål Tande</last_name>
    </contact>
    <contact_backup>
      <last_name>Henrik Schirmer</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <zip>3250</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bjørnar Grenne</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>Norway</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 22, 2014</study_first_submitted>
  <study_first_submitted_qc>November 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2014</study_first_posted>
  <last_update_submitted>April 5, 2018</last_update_submitted>
  <last_update_submitted_qc>April 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Thor Edvardsen</investigator_full_name>
    <investigator_title>Professor, Chief department of Cardiology Oslo university hospital</investigator_title>
  </responsible_party>
  <keyword>Ejection fraction, Global Strain, Mechanical dispersion</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

